X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Bioengineering & Translational Medicine

期刊標題檢索 BIOENG TRANSL M 最新評論: Overall, I did a good job, and the speed was fast. However, it is imp... (2023-06-29)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Bioengineering & Translational Medicine]您好,您是該頁面的第 33020 位訪客。

期刊簡介
期刊名稱Bioengineering & Translational Medicine Bioengineering & Translational Medicine
LetPub Score
7.2
50 ratings
Rate

Reputation
8.6

Influence
6.0

Speed
7.0

期刊簡稱BIOENG TRANSL MED
ISSN2380-6761
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.401.6551.291
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q127 / 183
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Biomedical Engineering
Q161 / 303
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Biotechnology
Q164 / 311

自引率 (2023-2024)3.30%自引率趨勢
掲載範囲
官方網站http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2380-6761
在線稿件提交
開放訪問Yes
出版商Wiley-Blackwell
主題領域Pharmacology, Toxicology and Pharmaceutics
出版國/地區UNITED STATES
發行頻率
創刊年0
每年文章數152每年文章數趨勢
黃金OA百分比77.89%
OA Related Info
APC: Yes( USD2750; GBP1710; EUR2150; )
APC waiver:Check Notes
Other charges: No
Keywords: drug delivery、tissue engineering、synthetic biology、biosensors、biomolecular engineering、immunotherapy
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardPeer review、Anonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ENGINEERING, BIOMEDICALSCIEQ120/122
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2380-6761%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 12 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Bioengineering & Translational Medicine】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Asian Journal of Pharmaceutical SciencesH-index: 27

    CiteScore: 18.30
    Journal of Pharmaceutical InvestigationH-index: 0

    CiteScore: 10.20
    PharmaceuticsH-index: 32

    CiteScore: 7.90
    Cancer NanotechnologyH-index: 0

    CiteScore: 5.20
    PharmaceuticalsH-index: 0

    CiteScore: 6.10
    Advanced TherapeuticsH-index: 0

    CiteScore: 7.10
    SCIENTIA PHARMACEUTICAH-index: 0

    CiteScore: 4.60
    BioImpactsH-index: 0

    CiteScore: 4.80
    Drug Metabolism LettersH-index: 0

    CiteScore: 2.80
    Recent Patents on Drug Delivery and FormulationH-index: 0

    CiteScore: 2.30
    學科內最受檢索的期刊 頁面查看次數
    Pharmaceutics120053
    Pharmaceuticals62825
    Asian Journal of Pharmaceutical Sciences56381
    Advanced Therapeutics26080
    Cancer Nanotechnology12723
    BioImpacts6958
    International Journal of Pharmaceutics: X3278
    Journal of Pharmaceutical Investigation3228
    Recent Patents on Drug Delivery and Formulation2795
    Drug Metabolism Letters2668
  •  

    Bioengineering & Translational Medicine Bioengineering & Translational Medicine
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Bioengineering & Translational Medicine] 的評論撰寫評論
作者: yangyangyang9999


領域: 医学
審稿時間: 6.0 month(s)
結果: 直接被接受


撰寫評論

2023-06-29 08:25:58 評論於
Overall, I did a good job, and the speed was fast. However, it is important to note that submitting for review does not guarantee an opportunity. Feedback is crucial when coming back.
(0) 讚! | yangyangyang9999

作者: 临窗观景1


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2023-05-27 15:11:32 評論於
The editors and reviewers are very professional, and the questions they raised are very valuable. I hope it will continue to improve.
(1) 讚! | 临窗观景1

作者: 花间笑


領域: 生物学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2022-12-08 20:34:56 評論於
Posted on July 19, 2022, major revisions on September 2, 2022, due to the slow progress in conducting experiments caused by the pandemic. Revised again on November 1, 2022, and accepted on December 1, 2022. Perhaps because the topic of the research is relatively niche, there were only two reviewers, but their comments were very fair and practical. I hope the journal continues to thrive!
(1) 讚! | 花间笑

作者: Ge Wang


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-13 20:47:50 評論於
Is it normal for 5 months to be under review?
(0) 讚! | Ge Wang

作者: 神学尽头的科学


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-13 07:29:51 評論於
Are you still there?
(0) 讚! | 神学尽头的科学

作者: 神学尽头的科学


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-05 18:47:01 評論於
May I ask, it has been almost two weeks since I submitted to this journal, but it has been under review from the beginning and is still with the editor. Could you please tell me what changes in status occur during the submission process? How can I confirm if it has been sent for external review? Thank you so much.
(0) 讚! | 神学尽头的科学

作者: 吃树好吃


領域: 医学
審稿時間: 12.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-06 09:45:05 評論於
Hello, I submitted my manuscript on October 31st. On January 2nd, the status changed from "under review" to "pending recommendation," and it has remained the same since then. How long does "pending recommendation" usually last? I have previously sent a reminder letter, but the editor has not replied...
(0) 讚! | 吃树好吃

作者: 邓昌平


領域: 生物学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2021-12-28 16:15:20 評論於
10-Oct-2021投;30-Oct-2021大修;20-Nov-2021修回;19-Dec-2021小修;20-Dec-2021修回;25-Dec-2021接收;整体投稿还算顺利,审稿人问题很有水平,很中肯,直击要害。

Translation: 
10-Oct-2021 Submission; 30-Oct-2021 Major revisions; 20-Nov-2021 Revisions submitted; 19-Dec-2021 Minor revisions; 20-Dec-2021 Revisions submitted; 25-Dec-2021 Accepted; The overall submission process went smoothly, the reviewers' questions were insightful and fair, hitting the key points.
(0) 讚! | 邓昌平

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Bioengineering & Translational Medicine] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*